[REGN] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
04-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -47.33%
YoY- 93.82%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 2,857,200 2,965,100 4,951,700 3,452,800 5,138,500 2,528,700 2,422,900 11.65%
PBT 963,200 1,061,100 2,503,400 1,816,600 3,752,800 1,253,000 1,224,600 -14.82%
Tax 111,100 87,600 274,400 184,400 653,900 137,800 75,400 29.57%
NP 852,100 973,500 2,229,000 1,632,200 3,098,900 1,115,200 1,149,200 -18.12%
Tax Rate -11.53% -8.26% -10.96% -10.15% -17.42% -11.00% -6.16% -
Total Cost 2,005,100 1,991,600 2,722,700 1,820,600 2,039,600 1,413,500 1,273,700 35.43%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 29.82 32.83 45.01 47.27 60.31 44.10 47.43 -26.67%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS 7.47 8.61 20.99 15.37 29.51 10.58 10.90 -22.32%
EPS Diluted 7.47 8.61 19.69 14.33 27.97 10.09 10.24 -19.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.